| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 12/11/2002 | EP1263936A1 Altered strain of the modified vaccinia virus ankara (mva) |
| 12/11/2002 | EP1263933A2 Treatment for bone disorders |
| 12/11/2002 | EP1263932A1 Embryonic stem cells and neural progenitor cells derived therefrom |
| 12/11/2002 | EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 12/11/2002 | EP1263786A2 Methods and compositions for immunoregulation |
| 12/11/2002 | EP1263784A1 Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 12/11/2002 | EP1263766A1 Adam polynucleotides, polypeptides, and antibodies |
| 12/11/2002 | EP1263765A1 ALTERATION OF CELLULAR BEHAVIOR BY ANTISENSE MODULATION OF mRNA PROCESSING |
| 12/11/2002 | EP1263475A2 Synthetic oligonucleotides as inducers of erythroid differentiation |
| 12/11/2002 | EP1263474A1 A method of sensitising endothelial cells to prodrugs |
| 12/11/2002 | EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function |
| 12/11/2002 | EP1263461A1 Adenovirus formulations |
| 12/11/2002 | EP1263456A2 A method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia" |
| 12/11/2002 | EP1263455A2 Uses of bombesin receptor 3 |
| 12/11/2002 | EP1263452A2 Methods and compositions for generating angiostatin |
| 12/11/2002 | EP1263449A1 Induction of beta cell differentiation in human cells by stimulation of the glp-1 receptor |
| 12/11/2002 | EP1263446A2 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene |
| 12/11/2002 | EP1263436A1 Use of glucosylceramide synthesis inhibitors in brain cancertherapy |
| 12/11/2002 | EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases |
| 12/11/2002 | EP0802985B1 Cell cycle regulated repressor and dna element |
| 12/11/2002 | CN1384884A Herpes virus vectors for dendritic cells |
| 12/11/2002 | CN1384883A Production of recombinant respiratory syncytical viruses expressing immune modulatory molecules |
| 12/11/2002 | CN1384881A Compositions and methods for non-targeted activation of endogenous genes |
| 12/11/2002 | CN1384878A IREN protein, its preparation and use |
| 12/11/2002 | CN1384876A Modular transport systems for molecular substances and production and use thereof |
| 12/11/2002 | CN1384759A Single-stranded oligodeoxynucleotide mutional vectors |
| 12/11/2002 | CN1384758A Mutant human CD80 and copositions for and methods of making and using the same |
| 12/11/2002 | CN1384757A Method for down-regulating GDF-8 activity |
| 12/11/2002 | CN1384200A Genetically engineered body of farm animal castration gene vaccine (DNA vaccine) |
| 12/11/2002 | CN1095677C 化合物 Compound |
| 12/10/2002 | USRE37933 Locally administering to mammalian vascular smooth muscle cells replication defective recombinant adenovirus comprising gene encoding mammalian gax protein, wherein gene is expressed and proliferation of cells is inhibited |
| 12/10/2002 | US6492504 Nucleotide sequence of mammastatin and methods of use |
| 12/10/2002 | US6492343 Porcine adenovirus type 3 genome |
| 12/10/2002 | US6492324 APJ ligand polypeptides |
| 12/10/2002 | US6492173 Anticarcinogenic agents |
| 12/10/2002 | US6492170 Antisense modulation of caspase 9 expression |
| 12/10/2002 | US6492169 Complementing cell lines |
| 12/10/2002 | US6492166 Use of constitutive transport elements for host range control |
| 12/10/2002 | US6492165 Retrovirus isolated from humans |
| 12/10/2002 | US6492164 Circular DNA expression cassettes for gene transfer |
| 12/10/2002 | US6492157 Methods are provided for the treatment of conditions associated with cells proliferation, cells differentiation and cell survival. in particular, the dual-specificity phosphatase dsp-9, and polypeptide variants thereof that |
| 12/10/2002 | US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf |
| 12/10/2002 | US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 12/10/2002 | US6492112 Mitogen-activated protein kinase kinase 7 (MKK7) |
| 12/10/2002 | US6491921 Nucleic acids immunology vectors comprising eukaryotic transcription or translation gene expression controllers having enhancers and codes for immunogen polypeptides used against infections |
| 12/10/2002 | US6491908 Selective elimination of T cells that recognize specific preselected targets |
| 12/10/2002 | US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells |
| 12/10/2002 | US6491906 CXC chemokines as regulators of angiogenesis |
| 12/10/2002 | US6491905 Recombinant bacterial cells for delivery of PNP to tumor cells |
| 12/10/2002 | CA2239195C Ceramic packing with channels for thermal and catalytic beds |
| 12/10/2002 | CA2196085C Mhc complexes and uses thereof |
| 12/10/2002 | CA2080182C Nuclear inhibitor i-92 and its use for the production of a medicament |
| 12/05/2002 | WO2002097395A2 P-cadherin as a target for anti-cancer therapy |
| 12/05/2002 | WO2002097134A2 Modified peptide nucleic acid |
| 12/05/2002 | WO2002097127A2 Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease |
| 12/05/2002 | WO2002097125A2 Tools for the diagnosis, molecular definition and development of treatment of chronic inflammatory joint diseases |
| 12/05/2002 | WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 12/05/2002 | WO2002097116A2 Delivery system for nucleic acids |
| 12/05/2002 | WO2002097108A2 Antisense modulation of dual specific phosphatase 5 expression |
| 12/05/2002 | WO2002097104A1 Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes |
| 12/05/2002 | WO2002097087A1 Method of expressing foreign gene in kidney |
| 12/05/2002 | WO2002097070A1 Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof |
| 12/05/2002 | WO2002097059A2 Chromosome-based platforms |
| 12/05/2002 | WO2002097056A2 Method for generating replication defective viral vectors that are helper free |
| 12/05/2002 | WO2002097046A2 B7 related protein-2 molecules and uses thereof |
| 12/05/2002 | WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 12/05/2002 | WO2002097043A2 Wnv core protein/capsid interacting protein and uses of the same |
| 12/05/2002 | WO2002097030A2 Peptides derived from neural thread proteins and their medical use |
| 12/05/2002 | WO2002096939A2 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 12/05/2002 | WO2002096927A2 Ribozyme based treatment of female reproductive diseases |
| 12/05/2002 | WO2002096926A1 Modulators of pharmacological agents |
| 12/05/2002 | WO2002096469A2 Gene delivery via a baculovirus vector |
| 12/05/2002 | WO2002096467A2 Pharmaceutical use for secreted bacterial effector proteins |
| 12/05/2002 | WO2002096456A1 Use of il-18 inhibitors for treating or preventing cns injuries |
| 12/05/2002 | WO2002096396A1 Fine inorganic particles having drug included therein, method for preparation thereof and pharmaceutical preparation comprising fine inorganic particles having drug included therein |
| 12/05/2002 | WO2002096390A1 Neutral-cationic lipid for systemic delivery of factor viii gene |
| 12/05/2002 | WO2002096364A2 Feline bronchioloalveolar lung carcinoma xenograft and cell line |
| 12/05/2002 | WO2002096349A2 Vaccination against the feline immunodeficiency virus |
| 12/05/2002 | WO2002096216A1 A method of improving the growth performance of an animal |
| 12/05/2002 | WO2002096195A1 Treatment or replacement therapy using transgenic stem cells delivered to the gut |
| 12/05/2002 | WO2002070557A3 Nuclear hormone receptor ligand binding domain |
| 12/05/2002 | WO2002068470A3 Interferon-alpha induced gene |
| 12/05/2002 | WO2002064757A3 Influenza viruses with enhanced transcriptional and replicational capacities |
| 12/05/2002 | WO2002053756A3 Regulation of human glucosamine-6-phosphate deaminase |
| 12/05/2002 | WO2002053749A3 Regulation of human serine-threonine protein kinase |
| 12/05/2002 | WO2002053110A3 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 12/05/2002 | WO2002048384A3 Nucleic acid sequence 'm73791' serving as a human gene, and derivatives thereof |
| 12/05/2002 | WO2002031126A3 Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase |
| 12/05/2002 | WO2002024950A3 Methods and means of rna analysis |
| 12/05/2002 | WO2002016413A3 Cripto tumour polypeptide |
| 12/05/2002 | WO2002006453A3 Regulation of human desc1-like serine protease |
| 12/05/2002 | WO2001094605A3 Recombinant aav vectors for gene therapy of obesity |
| 12/05/2002 | WO2001090142A3 FULL LENGTH HUMAN HCN1 Ih CHANNEL SUBUNIT AND VARIANTS |
| 12/05/2002 | WO2001073016A3 Regulation of human tap-related protein |
| 12/05/2002 | WO2001064949B1 Diagnostics and therapeutics for glaucoma |
| 12/05/2002 | WO2001062928A3 Polypeptides and nucleic acids encoding same |
| 12/05/2002 | WO2001032926A3 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 12/05/2002 | WO2001032685A9 Gene expression directed by a super-psa promoter |
| 12/05/2002 | US20020183508 Sequences of hepatitis C virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |
| 12/05/2002 | US20020183507 Novel human GABA receptor proteins and polynucleotides encoding the same |